Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional)

Funder: National Institute of Health (NIH)

Deadline: 01/11/2021

Award Details: NIMH and partner components intend to commit an estimated total of $3M in FY 2021 to fund 6-9 awards in response to this FOA and the companion (RFA-MH-21-151). Direct costs are limited to $450,000 over the R34 project period, with no more than $225,000 in direct costs allowed in any single year.

Number of Awards: NIMH and partner components intend to commit an estimated total of $3M in FY 2021 to fund 6-9 awards in response to this FOA and the companion (RFA-MH-21-151). Direct costs are limited to $450,000 over the R34 project period, with no more than $225,000 in direct costs allowed in any single year.

Target Population: Research suggests limited PrEP awareness and use in the southern U.S. despite a high proportion of eligibility and acceptability. Once informed of PrEP, both cisgender and transgender women in this region encounter a variety of barriers to PrEP uptake that stem from social, economic, structural, and institutional sources of influence. Barriers to use include concerns about costs related to PrEP; need to maintain high rates of adherence; side effects that result from PrEP use alone and drug-drug interactions; and fear of negative perceptions from partners and family. For marginalized communities, a history of medical mistrust and negative patient-provider interactions can deter clinic-based discussions on perceived HIV risk and subsequent PrEP use.
Barriers to use may include substance use (including opioids and stimulants) and psychiatric disorders, exposure to intimate partner violence, marginal housing, and material insufficiencies. In turn, addressing unmet needs for substance use disorder treatment, harm reduction, mental health care, and adequate social service support may enhance uptake of PrEP and other HIV preventionpractices.
This initiative will support research to improve the uptake of and adherence to HIV prevention strategies among women in the southern U.S. by developing and testing interventions designed to address barriers and facilitators to HIV prevention use within this priority population.

Eligibility:

Higher Education Institutions

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

  • Small Businesses
  • For-Profit Organizations (Other than Small Businesses)

Local Governments

  • State Governments
  • County Governments
  • City or Township Governments
  • Special District Governments
  • Indian/Native American Tribal Governments (Federally Recognized)
  • Indian/Native American Tribal Governments (Other than Federally Recognized)

Federal Governments

  • Eligible Agencies of the Federal Government
  • U.S. Territory or Possession

Other

  • Independent School Districts
  • Public Housing Authorities/Indian Housing Authorities
  • Native American Tribal Organizations (other than Federally recognized tribal governments)
  • Faith-based or Community-based Organizations
  • Regional Organizations


Link to RFP: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-150.html